CD70 and non-small cell lung carcinoma: Further, ADP-520 demonstrated robust cytotoxicity and cytokine production against additional CD70-expressing cell lines, including the MJ (Supplementary Figure 3B) and HuT78 (Supplementary Figure 3C) T-cell lymphoma cell lines, and the non-small cell lung cancer (NSCLC) line, NCI-H1975 (Supplementary Figure 3D).